Tool for Pharmacovigilance: for Infectious Disease, Combat Casuality Care and Biological Warfare and Chemical Defense Medications and Vaccines

Ontar proposes to design and implement a pharmacovigilance system and analytic database to rapidly and accurately evaluate the safety of marketed and to-be-developed drugs, vaccines or other treatment agents from disparate pre- and post-marketing clinical data trials and other sources. This will include development of a data mining tool to detect both known and unknown safety signals in the FDA, WHO, CHCS, clinical trials and other databases; provide careful, innovative data preparation (code mapping, redundancy removal); develop advanced screening algorithms; implementation of user-friendly interfaces (including a web-based portal) and cognitive report displays. The system can form part of an active surveillance system to provide rapid and accurate safety signal evaluation, or can be used as a medical investigative product for both military and civilian (i.e. pharmaceutical and health industry) purposes.